Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.71 - $0.97 $12,065 - $16,484
16,994 Added 27.09%
79,719 $73,000
Q3 2023

Nov 14, 2023

BUY
$0.96 - $2.01 $11,086 - $23,211
11,548 Added 22.56%
62,725 $62,000
Q2 2023

Aug 14, 2023

BUY
$1.59 - $2.29 $4,998 - $7,199
3,144 Added 6.55%
51,177 $90,000
Q1 2023

May 15, 2023

SELL
$2.05 - $2.87 $25,770 - $36,078
-12,571 Reduced 20.74%
48,033 $110,000
Q4 2022

Feb 14, 2023

SELL
$2.06 - $3.47 $33,139 - $55,821
-16,087 Reduced 20.98%
60,604 $131,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $63,138 - $124,334
24,284 Added 46.34%
76,691 $220,000
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $69,657 - $126,591
31,807 Added 154.4%
52,407 $130,000
Q4 2021

Feb 14, 2022

BUY
$6.55 - $13.25 $134,930 - $272,950
20,600 New
20,600 $137,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.